Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.

Employee Rating

3.7More
TypePublic
HQSummit, US
Founded1986
Size (employees)7,467 (est)
Websitecelgene.com
Celgene was founded in 1986 and is headquartered in Summit, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Celgene

Mark J. Alles

Mark J. Alles

Chairman and Chief Executive Officer
Peter N. Kellogg

Peter N. Kellogg

Executive Vice President and Chief Financial Officer
Nadim Ahmed

Nadim Ahmed

President, Hematology & Oncology
Terrie Curran

Terrie Curran

President, Inflammation and Immunology
Rupert Vessey

Rupert Vessey

Executive Vice President and President, Research and Early Development
Jonathan Biller

Jonathan Biller

Executive Vice President and General Counsel
Show more

Celgene Office Locations

Celgene has offices in Singapore, Summit and Boudry
Summit, US (HQ)
86 Morris Avenue Summit
Singapore, SG
200 Newton Road #04-01, Newton 200
Boudry, CH
Route de Perreux 1
Show all (3)
Report incorrect company information

Celgene Financials and Metrics

Celgene Revenue

Embed Graph
Celgene's revenue was reported to be $13 b in FY, 2017
USD

Revenue (Q3, 2018)

3.9b

Gross profit (Q3, 2018)

3.7b

Gross profit margin (Q3, 2018), %

96%

Net income (Q3, 2018)

1.1b

EBIT (Q3, 2018)

1.7b

Market capitalization (9-Nov-2018)

51.8b

Closing stock price (9-Nov-2018)

74.0

Cash (30-Sep-2018)

2.5b

EV

49.8b
Celgene's current market capitalization is $51.8 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

6.5b7.7b9.3b11.2b13.0b

Revenue growth, %

18%21%21%

Cost of goods sold

340.4m385.9m420.1m438.0m461.0m

Gross profit

6.2b7.3b8.8b10.8b12.5b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q2, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

2.3b2.8b3.0b3.3b3.3b3.5b3.8b3.9b

Cost of goods sold

109.9m110.9m113.0m111.0m118.0m135.0m126.0m157.0m

Gross profit

2.2b2.6b2.8b3.2b3.2b3.4b3.7b3.7b

Gross profit Margin, %

95%96%96%97%96%96%97%96%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

3.2b4.1b4.9b6.2b7.0b

Inventories

340.4m393.1m443.4m497.9m541.0m

Current Assets

7.6b9.7b9.4b10.9b14.9b

PP&E

593.4m642.6m814.1m929.8m1.1b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

2.4b4.4b4.5b5.3b6.7b5.5b2.8b1.5b2.5b

Inventories

313.3m360.0m372.0m386.7m414.3m509.0m533.0m537.0m536.0m555.0m510.0m

Current Assets

7.6b6.9b8.1b9.7b9.9b8.4b9.2b11.6b13.1b14.8b7.9b6.9b7.8b

PP&E

592.3m649.7m675.2m702.0m840.0m854.0m958.0m989.0m1.0b1.3b1.3b1.3b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

1.4b2.0b1.6b2.0b2.9b

Depreciation and Amortization

471.0m

Inventories

(89.7m)(56.5m)(50.6m)(55.3m)(42.0m)

Cash From Operating Activities

2.2b2.8b2.5b4.0b5.2b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

1.2b1.4b718.9m1.0b800.7m1.4b941.0m2.0b3.0b846.0m1.9b3.0b

Depreciation and Amortization

71.8m28.1m29.2m58.5m32.0m240.0m355.0m126.0m296.0m465.0m

Inventories

(62.6m)(7.0m)7.3m(25.6m)(45.2m)(10.0m)(32.0m)(37.0m)6.0m(14.0m)31.0m

Cash From Operating Activities

1.7b856.5m974.9m1.9b853.0m2.5b3.6b(325.0m)904.0m2.8b
USDY, 2018

EV/EBIT

29.6 x

EV/CFO

17.6 x

EV/FCF

19.2 x

Debt/Equity

0.1 x

Financial Leverage

7 x
Show all financial metrics

Celgene Operating Metrics

FY, 2016

Active Clinical Studies

52
Show all operating metrics

Celgene Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Juno TherapeuticsJanuary 22, 2018$9 b
Impact BiomedicinesJanuary 07, 2018
Report incorrect company information

Celgene Online and Social Media Presence

Embed Graph
Report incorrect company information

Celgene Company Life and Culture

Report incorrect company information

Celgene Frequently Asked Questions

  • When was Celgene founded?

    Celgene was founded in 1986.

  • Who are Celgene key executives?

    Celgene's key executives are Mark J. Alles, Peter N. Kellogg and Nadim Ahmed.

  • How many employees does Celgene have?

    Celgene has 7,467 employees.

  • What is Celgene revenue?

    Latest Celgene annual revenue is $13 b.

  • What is Celgene revenue per employee?

    Latest Celgene revenue per employee is $1.7 m.

  • Who are Celgene competitors?

    Competitors of Celgene include Regeneron Pharmaceuticals, Sanofi and Gilead Sciences.

  • Where is Celgene headquarters?

    Celgene headquarters is located at 86 Morris Avenue Summit, Summit.

  • Where are Celgene offices?

    Celgene has offices in Singapore, Summit and Boudry.

  • How many offices does Celgene have?

    Celgene has 3 offices.